Development and synthesis of a non-specific immunomodulating peptidomimetic
... excellent CL and a moderate half-life. It was established that after three days of cultivation with the peptidomimetic, the number of DCs was 23.07 % higher (p < 0.05) compared with the negative control.
peptidomimetic, immunomodulatory effect, dendritic cells, toxicity, biological activity, pharmacokinetic properties
95-107
10.5922/vestniknat-2026-2-6
